Aik Na Tan
CIK: 0001821285
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Wave Life Sciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Oct 5, 2026WVE
Wave Life Sciences, Inc.
Award(A)Direct10.7K shares- - Aug 11, 2026WVE
Wave Life Sciences, Inc.
Sale(S)Direct432 shares at avg. $6.01$3K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Sale(S)Direct7.5K shares at avg. $12.75$96K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Sale(S)Direct7.5K shares at avg. $15.00$112K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Exercise(M)Direct32.2K shares at avg. $5.37$173K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Sale(S)Direct15K shares at avg. $12.75$191K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Sale(S)Direct17.2K shares at avg. $15.00$258K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Exercise(M)Direct45K shares at avg. $4.58$206K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Sale(S)Direct20K shares at avg. $12.75$255K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Sale(S)Direct25K shares at avg. $15.00$375K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Exercise(M)Direct21K shares at avg. $3.50$74K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Exercise(M)Direct21K shares at avg. $5.97$125K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Sale(S)Direct21K shares at avg. $12.75$268K - Dec 8, 2025WVE
Wave Life Sciences Ltd.
Sale(S)Direct21K shares at avg. $12.75$268K - Aug 15, 2025WVE
Wave Life Sciences Ltd.
Exercise(M)Direct21K shares at avg. $9.13$192K - Aug 15, 2025WVE
Wave Life Sciences Ltd.
Sale(S)Direct21K shares at avg. $9.25$194K - Aug 11, 2025WVE
Wave Life Sciences Ltd.
Award(A)Direct25.4K shares- - Aug 5, 2025WVE
Wave Life Sciences Ltd.
Sale(S)Direct1.1K shares at avg. $8.75$10K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | WVE Wave Life Sciences, Inc. | Award(A) | 10,700 | - | $0 | Direct |
| Aug 11, 2026 | WVE Wave Life Sciences, Inc. | Sale(S) | 432 | $6.01 | $2,596 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Sale(S) | 7,494 | $12.75 | $95,549 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Sale(S) | 7,494 | $15.00 | $112,410 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Exercise(M) | 32,230 | $5.37 | $173,075 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Sale(S) | 15,000 | $12.75 | $191,250 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Sale(S) | 17,230 | $15.00 | $258,450 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Exercise(M) | 45,000 | $4.58 | $206,325 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Sale(S) | 20,000 | $12.75 | $255,000 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Sale(S) | 25,000 | $15.00 | $375,000 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Exercise(M) | 21,000 | $3.50 | $73,500 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Exercise(M) | 21,000 | $5.97 | $125,370 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Sale(S) | 21,000 | $12.75 | $267,750 | Direct |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | Sale(S) | 21,000 | $12.75 | $267,750 | Direct |
| Aug 15, 2025 | WVE Wave Life Sciences Ltd. | Exercise(M) | 21,000 | $9.13 | $191,730 | Direct |
| Aug 15, 2025 | WVE Wave Life Sciences Ltd. | Sale(S) | 21,000 | $9.25 | $194,250 | Direct |
| Aug 11, 2025 | WVE Wave Life Sciences Ltd. | Award(A) | 25,400 | - | - | Direct |
| Aug 5, 2025 | WVE Wave Life Sciences Ltd. | Sale(S) | 1,127 | $8.75 | $9,861 | Direct |
1-18 of 18 transactions
About Tan Aik Na
Tan Aik Na (SEC CIK 0001821285) files insider reports with the SEC as Director of Wave Life Sciences, Inc. (WVE).
Signal8 holds 6 ownership filings by Tan Aik Na, all Form 4s, filed between Aug 7, 2025 and Oct 7, 2026. Those filings report 18 transactions, from Aug 5, 2025 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Tan Aik Na's filings is in CAMBRIDGE, MA.
Recent filings by Tan Aik Na
- Oct 5, 2026: Grant or award of WVE shares (Form 4, code A).
- Aug 11, 2026: Open-market sale of WVE shares (Form 4, code S).
- Dec 8, 2025: Open-market sales of WVE shares (2 lines, Form 4, code S).
- Dec 8, 2025: Option exercise of WVE shares (Form 4, code M).
- Dec 8, 2025: Open-market sales of WVE shares (2 lines, Form 4, code S).
Other insiders filing for Wave Life Sciences, Inc. (WVE)
- RA CAPITAL MANAGEMENT, L.P., Director
- Verdine Gregory L., Director
- TAKANASHI KEN, Director
- CORRIGAN MARK, Director
- Rawcliffe Adrian, Director
- Wagner Heidi L, Director